Item

European nations where virus first went mainstream nearly cleared as US cases soar

Title (Dublin Core)

European nations where virus first went mainstream nearly cleared as US cases soar

Description (Dublin Core)

Viral tweet today highlights the differences in cases between EU nations which were greatly hit by virus early on and the US. The days case increases of 190 for Italy, 81 for France, and 330 for Spain draw a stark contrast to America's over 33,000 new cases for today. The virus first drew mainstream attention in the west once it left China and started affecting western nations. Italy in particular was an early poster country for the pandemic, but now seems quaint compared the the United States.

I included this tweet because it essentially sums up the current status of the virus globally. European nations are almost clear of the virus due to strict pandemic guidelines. Meanwhile the United States has taken the opposite approach and any hope for the pandemic being over soon is officially gone. What struck me about this tweet was remembering the public reaction when Italy was the center point of the virus, and the denial of the US ever getting that bad. Now the story of the pandemic has shifted dramatically.

Date (Dublin Core)

Creator (Dublin Core)

Contributor (Dublin Core)

Event Identifier (Dublin Core)

Partner (Dublin Core)

Type (Dublin Core)

Screenshot of tweet

Link (Bibliographic Ontology)

Publisher (Dublin Core)

Twitter

Controlled Vocabulary (Dublin Core)

Curator's Tags (Omeka Classic)

Contributor's Tags (a true folksonomy) (Friend of a Friend)

Date Submitted (Dublin Core)

06/26/2020

Date Modified (Dublin Core)

07/11/2020
12/11/2020

Date Created (Dublin Core)

06/24/2020

Item sets

This item was submitted on June 26, 2020 by Armaan Sharma using the form “Share Your Story” on the site “A Journal of the Plague Year”: https://covid-19archive.org/s/archive

Click here to view the collected data.

New Tags

I recognize that my tagging suggestions may be rejected by site curators. I agree with terms of use and I accept to free my contribution under the licence CC BY-SA